Peak Pharmaceuticals, Inc. (OTCMKTS:PKPH – Get Free Report) shares dropped 0.6% during mid-day trading on Wednesday . The stock traded as low as $0.8548 and last traded at $0.8548. 101 shares changed hands during trading, a decline of 99% from the average daily volume of 9,053 shares. The stock had previously closed at $0.8603.
Peak Pharmaceuticals Price Performance
The stock’s fifty day moving average is $1.00 and its two-hundred day moving average is $1.66.
About Peak Pharmaceuticals
Peak Pharmaceuticals, Inc manufactures and markets pharmaceutical level products containing phytocannabinoids, an abundant and pharmaceutically active component of industrial hemp for the prevention and alleviation of various conditions and diseases. The company was founded on December 18, 2007 and is headquartered in Scottsdale, AZ.
Read More
- Five stocks we like better than Peak Pharmaceuticals
- Rocket Lab’s NASA Win Tests Key Support After Sharp Pullback
- AST SpaceMobile Just Nailed a Major Launch—So Why Is the Stock Crashing?
- Palantir’s Valuation Problem Just Met 2 New Growth Catalysts
- Xcel Energy Stock Offers Stability as Electricity Demand Builds
Receive News & Ratings for Peak Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Peak Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
